Pioglitazone is a drug that helps to reduce the bodys resistance to insulin. 미국 식품의약국에서 당뇨병 치료제로 승인되었습니다. Patients with HIV and HCV coinfections who have hepatic steatosis fatty liver may be eligible for this study.